Test–Retest Reliability of the Impact of Vision Impairment–Very Low Vision Questionnaire
Translational Vision Science & Technology · 2023
DOI: 10.1167/tvst.12.6.6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Vision Science & Technology, 2023. Verfasst von David J Fink und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University Hospital Bonn, Bonn, Germany. Hauptthemen laut MEDLINE: Vision, Low, Ophthalmology. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
Most patient-reported outcome measures used in ophthalmology show floor effects in a very low vision population, which limits their use in vision restoration trials. The Impact of Vision Impairment-Very Low Vision scale (IVI-VLV) was developed to specifically target a very low vision population, but its test-retest reliability has not been investigated yet.
Methods
The German version of the IVI-VLV was administered twice to patients with stable disease of a low vision clinic. Test and retest person measures of the IVI-VLV subscales were obtained from Rasch analysis. Test-retest reliability was investigated by intraclass correlation coefficients and Bland-Altman plots.
Results
We included 134 patients (72 women, 62 men) at a mean age of 62 ± 15 years. The intraclass correlation coefficients were 0.920 (95% confidence interval, 0.888-0.944) for the activities of daily living and mobility subscale of the IVI-VLV and 0.929 (95% confidence interval, 0.899-0.949) for the emotional well-being subscale. Bland-Altman plots did not indicate any systematic bias. In linear regression analysis, test-retest differences were not significantly associated with visual acuity or administration interval.
Conclusions
Both subscales of the IVI-VLV showed excellent repeatability independent of visual acuity and length of repeat interval. Further validation steps including an assessment of the patient-reported outcome measure's responsiveness are required for use in vision restoration trials. Translational Relevance: The results support repeated use of the IVI-VLV as a patient-reported end point in future studies in very low and ultralow vision populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Ophthalmology, University Hospital Bonn, Bonn, Germany.
- Department of Ophthalmology, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany.
Zitieren
APA
Fink, D. J., Terheyden, J. H., Pondorfer, S. G., Holz, F. G., & Finger, R. P. (2023). Test–Retest Reliability of the Impact of Vision Impairment–Very Low Vision Questionnaire. Translational Vision Science & Technology. https://doi.org/10.1167/tvst.12.6.6
Vancouver
Fink DJ, Terheyden JH, Pondorfer SG, Holz FG, Finger RP. Test–Retest Reliability of the Impact of Vision Impairment–Very Low Vision Questionnaire. Translational Vision Science & Technology. 2023. doi:10.1167/tvst.12.6.6
BibTeX
@article{Fink2023,
author = {Fink, David J and Terheyden, Jan H and Pondorfer, Susanne G and Holz, Frank G and Finger, Robert P},
title = {Test–Retest Reliability of the Impact of Vision Impairment–Very Low Vision Questionnaire},
journal = {Translational Vision Science & Technology},
year = {2023},
doi = {10.1167/tvst.12.6.6}
}
EUVIMED